The trial took place in a rural area hyper endemic for malaria, the hypothesis of which was that active detection and treatment of malaria in the population (all ages combined) in the event of a positive test could reduce the prevalence of malaria in the region. zoned. It was a two-armed, randomized, cluster-based community intervention trial: * one arm with home treatment of malaria for the duration of the study for patients with a positive result in the rapid diagnostic test for malaria. * a control arm with the usual malaria management procedures (ie consultation with community workers or the nearest health centers in the event of fever or suspected signs of malaria). Before the start of monitoring, an initial survey (Baseline) was carried out in the "fokontany" (villages / cluster) included in the 2 arms, in order to determine the prevalence of malaria. Then, in the intervention arm, screening for malaria by RDT every 2 weeks in subjects with a suspected malaria case (fever or notion of fever in the 2 days preceding the visit) and treatment with Artesunate-amodiaquine (ACT) for patients with a positive RDT. At the end of the follow-up period, a final survey (Endline), based on the same questionnaires as during the Baseline, was carried out in the 2 villages of the 2 arms. As a secondary objective, a study on anemia in women aged between 15 and 49 years was also carried out during the baseline and endline periods in order to compare the prevalence between the 2 periods
This study aims to compare the prevalence of malaria in the rural community of Mananjary after the Malaria Home Care Program (PECADOM Plus). The study will take place in fokontany rural communes of the district of Mananjary. This district was chosen for the following reasons: * High prevalence of malaria in this area (31% in subjects with fever and attending medical consultation in the CSB included in the sentinel IPM fever site) * presence of Peace Corps Volunteers (PCV) in this district. Mananjary District is situated in southeastern Madagascar, located in the central part of the Vatovavy Fitovinany Region, in the province of Fianarantsoa. It is located at 21°13'52" South and 48°20'31" East. The district is composed of one urban commune and 28 rural communes. After obtaining the agreement of the ethics committee for the realization of the study, the coordinator or the assistant coordinator of the project will make courtesy visits to all administrative and health officials in the Vatovavy Fitovinany and Mananjary District (Regional Directorate, District Chief ...).A random draw of fokontany meeting the inclusion criteria will be carried out later, to identify the distribution of fokontany in the intervention arm and control arm in the project. In addition to the 22 fokontany required, a draw of 8 reserve fokontany will be made (4 for each arm). A courtesy visit will be conducted in the fokontany raffled. The coordinator will check the number of inhabitants in these fokontany with the information gathered at the time of the preparation of the protocol (projection of the population according to the data of INSTAT, information from the Medical Inspector of Mananjary). If the fokontany will not be eligible, the reserve fokontany will replace them in the study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
1,000
CHWs in the intervention arm conducted door-to-door fever screening for all inhabitants of all consenting households in their catchment area every fortnight. All individuals with temperature ≥ 37.5°C or history of self-reported fever in the previous two weeks were tested with an RDT; positive individuals who were not pregnant and did not have signs of severe disease were treated with artesunate-amodiaquine according to treatment guidelines. Individuals identified as requiring a referral during Pro-CCM visits were assisted with transfer to the healthcare center, with transportation handled by the project staff.
Fokontany Andranomavo
Mananjary, : Fianarantsoa, Vatovavy Fitovinany, Madagascar
Fokontany Ambakoana
Mananjary, Fianarantsoa, Vatovavy Fitovinany, Madagascar
Fokontany Ambalamanasa
Mananjary, Fianarantsoa, Vatovavy Fitovinany, Madagascar
Fokontany Ambalaromba
Mananjary, Fianarantsoa, Vatovavy Fitovinany, Madagascar
Fokontany Ambinany Namorona
Mananjary, Fianarantsoa, Vatovavy Fitovinany, Madagascar
Fokontany Amboditandroho
Mananjary, Fianarantsoa, Vatovavy Fitovinany, Madagascar
Fokontany Ambohimiarina II
Mananjary, Fianarantsoa, Vatovavy Fitovinany, Madagascar
Fokontany Ambohinihaonana
Mananjary, Fianarantsoa, Vatovavy Fitovinany, Madagascar
Fokontany Ambolotara
Mananjary, Fianarantsoa, Vatovavy Fitovinany, Madagascar
Fokontany Andranomiteka
Mananjary, Fianarantsoa, Vatovavy Fitovinany, Madagascar
...and 12 more locations
The primary endpoint of the study was the change in the prevalence of malaria RDT positivity in the intervention versus control fokontany.
Difference in differences (DiD) approach comparing baseline to endline is used to compare the prevalence of malaria RDT positivity in the 2 arms
Time frame: an average of 1 year
percent of households visited every two weeks
percent of households visited every two weeks out of the number of the households registered in initial census
Time frame: The event was assessed up to 30 weeks (15 biweekly visits).
percent of households gave consent
percent of households that were visited every two weeks and gave consent for the screening during each visit
Time frame: The event was assessed up to 30 weeks (15 biweekly visits).
Fever incidence
percent of fever cases out of all individuals screened during each visit
Time frame: The event was assessed up to 30 weeks (15 biweekly visits).
Malaria incidence
percent of persons with positive RDT and fever cases out of all individuals screened during each visit
Time frame: The event was assessed up to 30 weeks (15 biweekly visits).
fever cases with RDT performed
percent of fever cases with RDT performed
Time frame: The event was assessed up to 30 weeks (15 biweekly visits).
RDT-positive persons treated with an ACT
percent of RDT-positive persons treated with an ACT during each visit
Time frame: The event was assessed up to 30 weeks (15 biweekly visits).
The change in the prevalence of anemia in women aged between 15 and 49 years old in the intervention versus control fokontany
Difference in differences (DiD) approach comparing baseline to endline is used to compare the prevalence of anemia in the 2 arms
Time frame: an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.